Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma Article (Faculty180)

cited authors

  • Ghandour, R A; Freifeld, Yuval; Cheaib, Joseph; Singla, Nirmish; Meng, Xiaosong; Kenigsberg, Alexander; Bagrodia, Aditya; Woldu, Solomon; Hoffman-Censits, Jean; Enikeev, Dmitry; Rapoport, Leonid; Petros, Firas G; Raman, Jay D; Pierorazio, Philip M; Matin, Surena F; Margulis, Vitaly

description

  • Neoadjuvant chemotherapy (NAC) is increasingly used prior to radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Systemic recurrence (SR) carries a dismal prognosis. We sought to determine risk factors associated with SR in this setting.

authors

publication date

  • 2021

published in

start page

  • 788.e15

end page

  • 788.e21

volume

  • 39